OLFML2B Antikörper (N-Term)

Produktnummer ABIN1881593

Produktdetails anti-OLFML2B Antikörper

Target: OLFML2B (Olfactomedin-Like 2B (OLFML2B))

Bindungsspezifität: AA 171-198, N-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser OLFML2B Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Homologie: M

Aufreinigung: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This OLFML2B antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 171-198 amino acids from the N-terminal region of human OLFML2B.

Klon: RB41588

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: WB: 1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Haltbarkeit: 6 months

Referenzen für anti-OLFML2B Antikörper (ABIN1881593)

Pfeufer, Sanna, Arking, Müller, Gateva, Fuchsberger, Ehret, Orrú, Pattaro, Köttgen, Perz, Usala, Barbalic, Li, Pütz, Scuteri, Prineas, Sinner, Gieger, Najjar, Kao, Mühleisen: "Common variants at ten loci modulate the QT interval duration in the QTSCD Study." in: Nature genetics, Vol. 41, Issue 4, pp. 407-14, (2009) (PubMed).

Newton-Cheh, Eijgelsheim, Rice, de Bakker, Yin, Estrada, Bis, Marciante, Rivadeneira, Noseworthy, Sotoodehnia, Smith, Rotter, Kors, Witteman, Hofman, Heckbert: "Common variants at ten loci influence QT interval duration in the QTGEN Study." in: Nature genetics, Vol. 41, Issue 4, pp. 399-406, (2009) (PubMed).

McGeachie, Ramoni, Mychaleckyj, Furie, Dreyfuss, Liu, Herrington, Guo, Lima, Post, Rotter, Rich, Sale, Ramoni: "Integrative predictive model of coronary artery calcification in atherosclerosis." in: Circulation, Vol. 120, Issue 24, pp. 2448-54, (2009) (PubMed).

Marroni, Pfeufer, Aulchenko, Franklin, Isaacs, Pichler, Wild, Oostra, Wright, Campbell, Witteman, Kääb, Hicks, Gyllensten, Rudan, Meitinger, Pattaro, van Duijn, Wilson, Pramstaller: "A genome-wide association scan of RR and QT interval duration in 3 European genetically isolated populations: the EUROSPAN project." in: Circulation. Cardiovascular genetics, Vol. 2, Issue 4, pp. 322-8, (2009) (PubMed).

Hanna, Kruskal, Ezekowitz, Bloom, Collier: "Role of macrophage oxidative burst in the action of anthrax lethal toxin." in: Molecular medicine (Cambridge, Mass.), Vol. 1, Issue 1, pp. 7-18, (1996) (PubMed).

Details zu OLFML2B

Target: OLFML2B (Olfactomedin-Like 2B (OLFML2B))

Andere Bezeichnung: OLFML2B (OLFML2B Produkte)

Synonyme: RP11-227F8.1 antikoerper, 1110018N05Rik antikoerper, 4832415H08Rik antikoerper, AI467542 antikoerper, olfactomedin like 2B antikoerper, olfactomedin-like 2B antikoerper, olfactomedin-like 2Bb antikoerper, OLFML2B antikoerper, Olfml2b antikoerper, olfml2bb antikoerper

Hintergrund: OLFML2B contains 1 olfactomedin-like domain.

Molekulargewicht: 83999

NCBI Accession: NP_056256

UniProt: Q68BL8